Zoledronic acid cost effective in preventing AI-associated bone loss Clinical study 13 February 2013 Pages: 1 - 1
A recipe for disaster: can US healthcare woes be turned around? Comment 13 February 2013 Pages: 2 - 2
Epinephrine has been confirmed as the drug of choice for anaphylaxis Review 13 February 2013 Pages: 3 - 3
Katrina prompts less-than-perfect antihypertensive adherence Clinical study 13 February 2013 Pages: 5 - 5
The administration of the DTaP vaccine in the NICU is an effective way to increase the rates of vaccination Clinical study 13 February 2013 Pages: 5 - 5
Vaccine coverage better but still not optimal for US young people Media release 13 February 2013 Pages: 5 - 5
Health care costs for children with Down's syndrome “substantial” Clinical study 13 February 2013 Pages: 6 - 6
Trial participants would do it again, regardless of financial information Clinical study 13 February 2013 Pages: 6 - 6
Cost effectiveness of costimulation modulator in anti-TNF-resistant RA Clinical study 13 February 2013 Pages: 8 - 8
Palliative chemotherapy increases survival in metastatic colon cancer Clinical study 13 February 2013 Pages: 8 - 8
The Centers for Disease Control and Prevention expanded the flu vaccination programme recommendations Media release 13 February 2013 Pages: 8 - 8
Generic carve-outs would increase costs by $US29b over next decade Media release 13 February 2013 Pages: 9 - 9
Cancer patients in Alberta, Canada, will now have better access to aprepitant, Media release 13 February 2013 Pages: 9 - 9
Canadian First Nations people living with HIV/AIDS will now have access to raltegravir Media release 13 February 2013 Pages: 9 - 9
The European Commission, the EMEA and the US FDA have affirmed their commitment to regulatory cooperation Media release 13 February 2013 Pages: 10 - 10
The launch of new therapies and increased uptake of current agents will bolster the neuropathic pain market Media release 13 February 2013 Pages: 10 - 10
Merck & Co's live, oral, pentavalent rotavirus vaccine [Rotateq] has been awarded prequalification status by WHO. Media release 13 February 2013 Pages: 10 - 10
The province of Quebec has announced that it will include sitagliptin [Januvia], under some reimbursement criteria, Media release 13 February 2013 Pages: 11 - 11
US Congress has passed a mental health parity bill, which is a great step forward in ending insurance discrimination for people seeking treatment for mental health and substance use disorders. Media release 13 February 2013 Pages: 11 - 11